Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?
- 1 March 2007
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 20 (1) , 29-37
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Hematotoxicity in Workers Exposed to Low Levels of BenzeneScience, 2004
- Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantationBlood, 2004
- In Reply:Journal of Clinical Oncology, 2003
- Morphologic Dysplasia in Acute Myeloid Leukemia: Importance of Granulocytic DysplasiaJournal of Clinical Oncology, 2003
- Morphologic Dysplasia in De Novo Acute Myeloid Leukemia (AML) Is Related to Unfavorable Cytogenetics but Has No Independent Prognostic Relevance Under the Conditions of Intensive Induction Therapy: Results of a Multiparameter Analysis From the German AML Cooperative Group StudiesJournal of Clinical Oncology, 2003
- World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997Journal of Clinical Oncology, 1999
- The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 TrialBlood, 1998
- Radon as a causative factor in induction of myeloid leukaemia and other cancersThe Lancet, 1990
- Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome.Journal of Clinical Oncology, 1989
- Benzene and LeukemiaNew England Journal of Medicine, 1987